Brief: Automodular corporation Q4 loss per share c$0.03
09/03/2017 16:04
March 9 (Reuters) - Automodular Corp:
* Automodular corporation: 2016 results
* Q4 loss per share c$0.03
Source text for Eikon: ID:nCCN6RjHPQ
Further company coverage: AMh.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease